Access to medications for opioid use disorder in Oklahoma: Barriers to care and policy solutions
Decades of research and positive clinical outcomes have established medications for opioid use disorder (MOUD) as the gold standard for treating opioid use disorder, but many Oklahomans who need this treatment face significant hurdles in accessing it.
In Oklahoma, about 2% of adults, or more than 67,000 people, have opioid use disorder, higher than the national average of 1.4%, according to 2024–2025 data from the National Survey on Drug Use and Health. Nationally, only about one in five adults with opioid use disorder received medication-based treatment, the front-line approach.
In this analysis, we offer the most complete look to date at the state of treatment for opioid use disorder (OUD) in Oklahoma. We explore the evidence for MOUD as the standard of care, examine the state’s treatment network and regulatory landscape, and highlight barriers that limit access to MOUD and impact treatment outcomes.
Finally, we offer recommendations for Oklahoma policymakers and state agency leaders to strengthen the state’s addiction treatment infrastructure and increase access to medication-based treatment statewide.
Key takeaways
- Access to MOUD varies widely across the state — only about 41% of the state is within a 30-minute drive to any MOUD facility, and access to methadone facilities is even more limited. Federal changes to expand access to telehealth prescribing and mobile MOUD have increased access in some areas, and Oklahoma should work to extend these improvements statewide.
- High risk populations, like pregnant women and people involved with the criminal justice system, encounter even greater barriers to treatment access. Less than half of Oklahoma counties have at least one jail-based MOUD program, and only two facilities in the state are dedicated to offering comprehensive perinatal care along with access to outpatient medication-based treatment.
- Insurers’ prior authorization requirements can delay patients from starting and continuing substance use treatment, which can increase health care costs, restrict providers from following best practices, and ultimately worsen treatment and mortality outcomes. Policymakers should move to limit insurers from requiring clinically unnecessary prior authorizations for MOUD.
- Oklahomans seeking treatment for opioid addiction are offered different treatment standards and can face more restrictive policies and participation requirements depending on where they live and seek care. Standardizing statutory and regulatory expectations and site-level participation policies for opioid treatment programs across the state to align with federal guidelines and national best practices could improve patient retention rates and treatment outcomes and streamline service provision and administrative compliance for treatment providers.
- Unstable state and federal funding further complicate these challenges, especially for safety net providers, which makes long-term planning difficult for providers and can hurt treatment outcomes. For example, a state mental health agency budget shortfall in 2025 led to hundreds of contracts being cut, including ones that fund mental health and addiction services.
